Compare Kotak Healthcare Fund vs SBI Healthcare Opportunities Fund
Kotak Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.55
1.99
NAV
₹16.74
₹559.17
Fund Started
20 Nov 2023
04 Jun 1999
Fund Size
₹825.14 Cr
₹5870.00 Cr
Exit Load
0.5% for redemption within 30 Days
Exit load of 0.50% if redeemed within 15 days
1 Year
16.23%
9.93%
3 Year
-
20.31%
5 Year
-
16.00%
Equity
98.69%
95.53%
Cash
1.31%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.21% |
Divi's Laboratories Ltd. | 9.35% |
Molbio Diagnostics Ltd. | 5.08% |
Torrent Pharmaceuticals Ltd. | 4.65% |
Acutaas Chemicals Ltd. | 4.17% |
Max Healthcare Institute Ltd. | 3.61% |
Cipla Ltd. | 3.26% |
Park Medi World Ltd. | 3.17% |
Gland Pharma Ltd. | 3.16% |
Yatharth Hospital & Trauma Care Services Ltd. | 3.12% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
20 Nov 2023
04 Jun 1999
